Form 4: Rocket Lab CEO's Family Trust Converts Preferred Stock to Common for Future Sales

Peter Beck's family trust, Equatorial Trust, has converted 5 million shares of Rocket Lab Series A Preferred Stock into Common Stock, signaling future sales under a pre-arranged 10b5-1 plan.

Summary

• Peter Beck, President, CEO, and Chairman of Rocket Lab Corporation, along with Kerryn Beck and Warren Butler, are reporting persons associated with the Equatorial Trust.
• On June 17, 2025, the Equatorial Trust, a family trust settled by Peter Beck and Kerryn Beck, converted 5,000,000 shares of Series A Convertible Participating Preferred Stock into 5,000,000 shares of Common Stock.
• Each share of Series A Preferred Stock is convertible into one share of Common Stock at the holder's option, subject to certain adjustments.
• Automatic conversion of Series A Preferred Stock held by the Trust is triggered by events such as sale/transfer (with exceptions), Peter Beck ceasing to be CEO, Peter Beck's death or permanent disability, or if Series A Preferred Stock falls below 5% of outstanding Common Stock.
• The conversion was undertaken to satisfy the delivery of Common Stock shares to a broker for sales planned in future months under a Rule 10b5-1 Plan.
• The Rule 10b5-1 Plan was adopted by the Trust on June 13, 2025.
• Sales under this plan are permitted to commence on September 15, 2025, and the plan will expire on December 17, 2025.
• Following this transaction, the Trust indirectly beneficially owns 45,951,250 shares of Common Stock.
• Peter Beck, Kerryn Beck, and Warren Butler, as directors of Peek Street Equatorial Trustee Limited (the Trustee of the Trust), share voting and investment control over these shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the implied future selling pressure from a significant insider's trust. While the 10b5-1 plan provides transparency, the intent to sell a large block of shares can be perceived as a negative signal by investors, even if it's for personal financial planning.

Positives

• The establishment of a Rule 10b5-1 plan provides transparency regarding future insider stock sales, reducing the perception of opportunistic trading.

Negatives

• The conversion of 5,000,000 shares of preferred stock into common stock for the purpose of future sales indicates an intent by the CEO's trust to liquidate a portion of its holdings, which could exert selling pressure on the stock price.

Risks

• Future sales of 5,000,000 shares of Common Stock by the Equatorial Trust between September 15, 2025, and December 17, 2025, could lead to increased supply in the market and potential downward pressure on Rocket Lab's share price.
• The automatic conversion triggers for Series A Preferred Stock, such as Peter Beck no longer serving as CEO or his death/permanent disability, introduce a future contingency that could lead to significant stock conversions and potential sales.

Future Outlook

The document indicates a future outlook of planned stock sales by a significant insider entity (the CEO's family trust) under a Rule 10b5-1 plan, with sales expected to occur between September 15, 2025, and December 17, 2025.

Management Comments

• The Trust converted the shares for purposes of satisfying delivery of shares of Common Stock to the broker for sales to be made in future months under a Rule 10b5-1 Plan adopted by the Trust on June 13, 2025.

Industry Context

This Form 4 filing details an insider transaction, which is a common occurrence for executives managing their personal holdings for diversification or liquidity. The use of a Rule 10b5-1 plan is a standard practice to execute pre-planned stock sales in compliance with insider trading regulations, providing a structured approach to avoid accusations of trading on material non-public information.

Related Party Transactions

• The transaction involves the Equatorial Trust, a family trust settled by Peter Beck (President, CEO, Chairman, Director, 10% Owner) and Kerryn Beck (10% Owner). Peter Beck, Kerryn Beck, and Warren Butler serve as directors of Peek Street Equatorial Trustee Limited, the trustee of the Trust, and share voting and investment control over the shares. This constitutes a related party transaction due to the direct involvement of key management and their family entities.

Stakeholder Impact

• Shareholders may experience potential selling pressure on Rocket Lab's common stock due to the planned future sales by the Equatorial Trust, which could impact the share price.
• The transparency provided by the 10b5-1 plan may offer some reassurance to investors regarding the pre-planned nature of the sales, rather than reactive trading.

Next Steps

• Sales of 5,000,000 shares of Common Stock by the Equatorial Trust are expected to commence on September 15, 2025, and conclude by December 17, 2025, under the Rule 10b5-1 Plan.

Key Dates

Keywords

Rocket Lab, RKLB, SEC Form 4, Insider Transaction, Stock Conversion, Preferred Stock, Common Stock, 10b5-1 Plan, Peter Beck, Equatorial Trust, Beneficial Ownership, Executive Stock Sales